These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35636037)

  • 21. A Bayesian learning model to predict the risk for cannabis use disorder.
    Rajapaksha RMDS; Filbey F; Biswas S; Choudhary P
    Drug Alcohol Depend; 2022 Jul; 236():109476. PubMed ID: 35588608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying HIV care enrollees at-risk for cannabis use disorder.
    Hartzler B; Carlini BH; Newville H; Crane HM; Eron JJ; Geng EH; Mathews WC; Mayer KH; Moore RD; Mugavero MJ; Napravnik S; Rodriguez B; Donovan DM
    AIDS Care; 2017 Jul; 29(7):846-850. PubMed ID: 28006972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
    Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in cannabis use disorders among racial/ethnic population groups in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Aug; 165():181-90. PubMed ID: 27317045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
    Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
    Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
    [No Abstract]   [Full Text] [Related]  

  • 27. DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles.
    Kerridge BT; Pickering R; Chou P; Saha TD; Hasin DS
    Addict Behav; 2018 Jan; 76():52-60. PubMed ID: 28755613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence.
    Peters EN; Schwartz RP; Wang S; O'Grady KE; Blanco C
    Drug Alcohol Depend; 2014 Jan; 134():228-234. PubMed ID: 24183498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Flórez-Salamanca L; Secades-Villa R; Budney AJ; García-Rodríguez O; Wang S; Blanco C
    Drug Alcohol Depend; 2013 Sep; 132(1-2):127-33. PubMed ID: 23415849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.
    Hefner K; Sofuoglu M; Rosenheck R
    Am J Addict; 2015 Sep; 24(6):538-45. PubMed ID: 26246069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-domain correlates of cannabis use disorder severity among young adults.
    Schuster RM; Hareli M; Moser AD; Lowman K; Gilman J; Ulysse C; Schoenfeld D; Evins AE
    Addict Behav; 2019 Jun; 93():212-218. PubMed ID: 30753972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use disorder and perioperative outcomes in vascular surgery.
    McGuinness B; Goel A; Elias F; Rapanos T; Mittleman MA; Ladha KS
    J Vasc Surg; 2021 Apr; 73(4):1376-1387.e3. PubMed ID: 32861869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis use and medication nonadherence in bipolar disorder: A nationwide inpatient sample database analysis.
    Oladunjoye AF; Kaleem SZ; Suresh A; Sahni V; Thoonkuzhy MJ; Anugwom G; Oladunjoye O; Otuada D; Ikekwere J; Espiridion ED
    J Affect Disord; 2022 Feb; 299():174-179. PubMed ID: 34863715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive validity of cannabis consumption measures: Results from a national longitudinal study.
    Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC
    Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.
    McBain RK; Wong EC; Breslau J; Shearer AL; Cefalu MS; Roth E; Burnam MA; Collins RL
    Drug Alcohol Depend; 2020 Oct; 215():108191. PubMed ID: 32736294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J
    J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities.
    Boyd CJ; Veliz PT; McCabe SE
    Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlates of patterns of cannabis use, abuse and dependence: evidence from two national surveys in Ireland.
    Millar SR; Mongan D; O'Dwyer C; Long J; Smyth BP; Perry IJ; Galvin B
    Eur J Public Health; 2021 Apr; 31(2):441-447. PubMed ID: 33624789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.